Spots Global Cancer Trial Database for adults
Every month we try and update this database with for adults cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma | NCT00445068 | Multiple Myelom... | LBH589 | 18 Years - | Novartis | |
| Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas | NCT02740270 | Solid Tumors Lymphomas | GWN323 PDR001 | 18 Years - | Novartis | |
| Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors | NCT02482506 | Breast Cancer | MF-WLP SG-WLP | 18 Years - 100 Years | Medical College of Wisconsin | |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| Losartan + Sunitinib in Treatment of Osteosarcoma | NCT03900793 | Osteosarcoma | Losartan Sunitinib | 10 Years - 40 Years | University of Colorado, Denver | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia | NCT03367299 | Acute Lymphoid ... Philadelphia Ch... | Chemotherapy + ... | 18 Years - 65 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib | NCT02398825 | Chronic Myeloid... Chronic Phase Adults | Ponatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | NCT00114920 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
| Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) | NCT00490776 | Cutaneous T-Cel... | Panobinostat | 18 Years - | Novartis | |
| Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase | NCT00451035 | Chronic Myeloid... | LBH589 | 18 Years - | Novartis | |
| Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies | NCT01802905 | Advanced Incura... | in depth genomi... | 18 Years - | British Columbia Cancer Agency | |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib | NCT02398825 | Chronic Myeloid... Chronic Phase Adults | Ponatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy | NCT04060706 | Cancer | Radical Image-G... | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase | NCT00449761 | Leukemia, Myelo... | LBH589 | 18 Years - | Novartis | |
| Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Squamous Cell Carcinoma | NCT06190275 | HNSCC Adults | GT201 in combin... | 18 Years - 70 Years | Grit Biotechnology | |
| Cancer Rehabilitation in Primary Health Care | NCT04316962 | Cancer Survivor... All Cancers | Complex cancer ... | 18 Years - 70 Years | University of Bergen | |
| Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC) | NCT03326765 | Sleep Disorder | Questionnaires electroencephal... polysomnography Actigraphy | 1 Day - 70 Years | Universitair Ziekenhuis Brussel | |
| Losartan + Sunitinib in Treatment of Osteosarcoma | NCT03900793 | Osteosarcoma | Losartan Sunitinib | 10 Years - 40 Years | University of Colorado, Denver | |
| Study With a Topical Gel to Treat Common Warts in Adults | NCT00117871 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
| ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma | NCT06149390 | T-cell Lymphoma... | consolidation w... | 18 Years - 75 Years | Huazhong University of Science and Technology | |
| African American Cancer Prevention Project: Establishing a Cohort to Investigate Health Disparities | NCT00823394 | Cancer | Questionnaire Body Measuremen... Self-help Mater... | 18 Years - | M.D. Anderson Cancer Center | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | NCT05476939 | Diffuse Intrins... Diffuse Midline... | Everolimus ONC201 Radiotherapy | 6 Months - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | NCT04671693 | Late Effects Testicular Germ... Non-Metastatic ... Soft Tissue Sar... Osteosarcoma Ewing's Sarcoma Acute Myeloid L... Hodgkin Disease Non Hodgkin Lym... | PASCA intervent... | 18 Years - 65 Years | Centre Leon Berard | |
| A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors | NCT00503451 | Non-Hodgkin Lym... Neoplasms | LBH589 | 18 Years - | Novartis | |
| Phase I Study of PDR001 in Patients With Advanced Malignancies. | NCT02678260 | Advanced Malign... | PDR001 | 18 Years - | Novartis | |
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health | NCT00145015 | Colorectal Canc... Ulcerative Coli... Polyps | Increased dieta... | 18 Years - 80 Years | Quadram Institute Bioscience | |
| Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia | NCT03751917 | Acute Promyeloc... | Arsenic Trioxid... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase | NCT00449761 | Leukemia, Myelo... | LBH589 | 18 Years - | Novartis | |
| Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL | NCT06175702 | Lymphoblastic L... Philadelphia-Po... Adult ALL | Vincristine Dexamethasone Imatinib Cytarabine Mercaptopurine Methotrexate Ponatinib allogeneic stem... Total body irra... Cyclophosphamid... Fludarabine | 18 Years - | PETHEMA Foundation | |
| Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase | NCT00451035 | Chronic Myeloid... | LBH589 | 18 Years - | Novartis | |
| Childhood Cancer Survivor Study | NCT01120353 | Cancer | - | St. Jude Children's Research Hospital | ||
| Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors | NCT02482506 | Breast Cancer | MF-WLP SG-WLP | 18 Years - 100 Years | Medical College of Wisconsin | |
| Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia | NCT00795756 | Acute Lymphobla... | liposome-encaps... Triple intrathe... | 18 Years - 65 Years | Northern Italy Leukemia Group | |
| Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain | NCT02522611 | Intractable Pai... Palliative Care | Resiniferatoxin | 18 Years - 150 Years | National Institutes of Health Clinical Center (CC) | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting | NCT04613765 | Adults Hematological M... Oral Antineopla... | Measure adheren... | 18 Years - | Jules Bordet Institute | |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | NCT06019130 | Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nivolumab Cisplatin 5-Fluorouracil Gemcitabine Radiotherapy Interferon beta... MRI PET Patient-Reporte... | 3 Years - | German Society for Pediatric Oncology and Hematology GPOH gGmbH | |
| Study With a Topical Gel to Treat Common Warts in Adults | NCT00117871 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
| Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib | NCT02398825 | Chronic Myeloid... Chronic Phase Adults | Ponatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas | NCT02740270 | Solid Tumors Lymphomas | GWN323 PDR001 | 18 Years - | Novartis | |
| Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain | NCT02522611 | Intractable Pai... Palliative Care | Resiniferatoxin | 18 Years - 150 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors | NCT00879905 | Advanced Solid ... | HSP990 | 18 Years - | Novartis | |
| Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | NCT00114920 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
| Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma | NCT05684874 | Soft Tissue Sar... Adult Soft Tiss... Resectable Soft... | Neoadjuvant RT Pre-radiotherap... Post-radiothera... Tumor resection | 18 Years - | Centre Leon Berard | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | NCT05476939 | Diffuse Intrins... Diffuse Midline... | Everolimus ONC201 Radiotherapy | 6 Months - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Study With a Topical Gel to Treat Common Warts in Adults | NCT00117923 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe | NCT00688753 | Carcinoma Renal Cell Non Clear Cell ... Papillary Cell ... Adenocarcinoma | RAD001 | 18 Years - | Novartis | |
| Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer | NCT02148159 | Malignant Neopl... | Cachexia Acupun... General Acupunc... | 21 Years - | University of Florida | |
| Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat | NCT02409134 | Quality of Life Graft-vs-Host D... | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | ||
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health | NCT00145015 | Colorectal Canc... Ulcerative Coli... Polyps | Increased dieta... | 18 Years - 80 Years | Quadram Institute Bioscience | |
| Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma | NCT05684874 | Soft Tissue Sar... Adult Soft Tiss... Resectable Soft... | Neoadjuvant RT Pre-radiotherap... Post-radiothera... Tumor resection | 18 Years - | Centre Leon Berard |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
